| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CCR6 | CD4 | ENSNMEP00000022239 | ENSNMEP00000019583 | C-C chemokine receptor type 6. | T-cell surface glycoprotein CD4 isoform X1. | 0.674 |
| CCR6 | CD40 | ENSNMEP00000022239 | ENSNMEP00000019064 | C-C chemokine receptor type 6. | Tumor necrosis factor receptor superfamily member 5 isoform X1. | 0.646 |
| CCR6 | CD83 | ENSNMEP00000022239 | ENSNMEP00000001550 | C-C chemokine receptor type 6. | CD83 antigen. | 0.671 |
| CCR6 | CD86 | ENSNMEP00000022239 | ENSNMEP00000019626 | C-C chemokine receptor type 6. | CD86 molecule. | 0.418 |
| CCR6 | IFNG | ENSNMEP00000022239 | ENSNMEP00000013494 | C-C chemokine receptor type 6. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons (By similarity). | 0.645 |
| CCR6 | IL10 | ENSNMEP00000022239 | ENSNMEP00000010576 | C-C chemokine receptor type 6. | Interleukin 10. | 0.538 |
| CCR7 | CD4 | ENSNMEP00000006783 | ENSNMEP00000019583 | C-C chemokine receptor type 7. | T-cell surface glycoprotein CD4 isoform X1. | 0.821 |
| CCR7 | CD40 | ENSNMEP00000006783 | ENSNMEP00000019064 | C-C chemokine receptor type 7. | Tumor necrosis factor receptor superfamily member 5 isoform X1. | 0.661 |
| CCR7 | CD83 | ENSNMEP00000006783 | ENSNMEP00000001550 | C-C chemokine receptor type 7. | CD83 antigen. | 0.625 |
| CCR7 | CD86 | ENSNMEP00000006783 | ENSNMEP00000019626 | C-C chemokine receptor type 7. | CD86 molecule. | 0.688 |
| CCR7 | IFNG | ENSNMEP00000006783 | ENSNMEP00000013494 | C-C chemokine receptor type 7. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons (By similarity). | 0.677 |
| CCR7 | IL10 | ENSNMEP00000006783 | ENSNMEP00000010576 | C-C chemokine receptor type 7. | Interleukin 10. | 0.627 |
| CCR7 | LOC110401347 | ENSNMEP00000006783 | ENSNMEP00000011060 | C-C chemokine receptor type 7. | T-lymphocyte activation antigen CD80-like isoform X1. | 0.679 |
| CD4 | CCR6 | ENSNMEP00000019583 | ENSNMEP00000022239 | T-cell surface glycoprotein CD4 isoform X1. | C-C chemokine receptor type 6. | 0.674 |
| CD4 | CCR7 | ENSNMEP00000019583 | ENSNMEP00000006783 | T-cell surface glycoprotein CD4 isoform X1. | C-C chemokine receptor type 7. | 0.821 |
| CD4 | CD40 | ENSNMEP00000019583 | ENSNMEP00000019064 | T-cell surface glycoprotein CD4 isoform X1. | Tumor necrosis factor receptor superfamily member 5 isoform X1. | 0.819 |
| CD4 | CD74 | ENSNMEP00000019583 | ENSNMEP00000021410 | T-cell surface glycoprotein CD4 isoform X1. | HLA class II histocompatibility antigen gamma chain isoform X1. | 0.465 |
| CD4 | CD83 | ENSNMEP00000019583 | ENSNMEP00000001550 | T-cell surface glycoprotein CD4 isoform X1. | CD83 antigen. | 0.588 |
| CD4 | CD86 | ENSNMEP00000019583 | ENSNMEP00000019626 | T-cell surface glycoprotein CD4 isoform X1. | CD86 molecule. | 0.939 |
| CD4 | IFNG | ENSNMEP00000019583 | ENSNMEP00000013494 | T-cell surface glycoprotein CD4 isoform X1. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons (By similarity). | 0.916 |
